Biogen Inc

2026-09-04 23:46; UTC

Biogen Inc shares are lower in after-market hours, with no specific news driving the decline. Broader economic signals are contributing to market uncertainty.

2026-09-03 19:16; UTC

Biogen and Eisai received approval for LEQEMBI in China for early Alzheimer's treatment. Piper Sandler raised Biogen's price target to $245, maintaining an Overweight rating.

2026-09-02 23:56; UTC

Biogen Inc shares are higher in after-market trading, despite no specific news. Broader market dynamics may be influenced by weaker ADP payrolls data.

2026-09-01 21:01; UTC

Biogen Inc. shares are lower in after-market hours, continuing a downward trend over the past three sessions with no specific news identified.

2026-08-31 19:46; UTC

Biogen Inc's shares are lower amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh at the Jackson Hole symposium.

2026-08-28 21:01; UTC

Biogen Inc shares are lower in after-market hours, reflecting broader market weakness. No specific news was identified to explain the decline.

2026-08-26 20:08; UTC

Biogen Inc. has chosen Veeva Systems' Veeva Vault CRM to enhance its digital strategy, with shares rising during Wednesday's session amid positive sentiment.

2026-08-25 23:26; UTC

Biogen Inc. shares are trading roughly flat in after-market hours. Crude oil prices have declined, easing some geopolitical tensions, impacting overall market sentiment.

2026-08-24 20:13; UTC

Biogen Inc shares are trading lower in after-market hours. Broader market conditions may be influencing trading sentiment amid U.S.-Iran tensions and inflation concerns.

2026-08-21 20:06; UTC

Biogen Inc is trading higher since Thursday's close, reflecting positive market trends. The stock remains above its 20-day moving average despite a recent pullback.

2026-08-20 20:01; UTC

Shares lower today amid broader market declines and ETF drop.

2026-08-19 23:06; UTC

Biogen Inc. shares declined in after-market trading, moving lower since Wednesday's close. The asset remains above its 20-day moving average.

2026-08-17 19:46; UTC

Biogen Inc. shares are lower today amid routine trading, despite an unexpected rise in the New York manufacturing index supporting broader market conditions.

2026-08-14 22:36; UTC

Biogen Inc's shares are higher in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average and near its monthly range high.

2026-08-13 20:06; UTC

Wolfe Research upgraded Biogen to Outperform, raising its price target to $300, citing a promising late-stage pipeline and recent acquisition of Apellis Pharmaceuticals.

2026-08-12 23:01; UTC

Biogen shares are lower in after-market trading with no specific news identified. The stock remains above its 20-day moving average.

2026-08-11 23:46; UTC

Biogen Inc shares are modestly higher in after-market trading. No specific news was identified to explain the movement amid broader market focus on economic indicators.

2026-08-10 19:36; UTC

Biogen Inc has completed its $1 billion acquisition of RayThera. Shares are trading lower despite the strategic development and potential pipeline enhancement.

2026-08-07 23:16; UTC

Biogen Inc completed the acquisition of RayThera, valued at up to $1 billion, but shares are lower in after-market trading.

2026-08-06 23:11; UTC

Biogen Inc. has completed its acquisition of RayThera Inc., enhancing its immunology portfolio. Shares are trading lower in after-market hours following a recent decline.

2026-08-05 19:26; UTC

Biogen Inc reported second-quarter revenue of $2.74 billion, exceeding estimates. Despite strong results, shares are trading lower amid broader market declines.

2026-08-04 20:02; UTC

Mizuho raised its price target on Biogen Inc. to $241, contributing to the stock's upward movement during Tuesday's session.

2026-08-03 23:06; UTC

Biogen Inc. shares are trading higher in after-market hours, supported by stronger-than-expected manufacturing data and positive broader market sentiment.

2026-07-31 21:01; UTC

Biogen Inc reported second-quarter revenue of $2.74 billion, exceeding estimates. Shares are higher in after-market trading following the positive results and raised EPS guidance.

2026-07-30 19:39; UTC

Biogen Inc shares are lower in Thursday's session, reaching a low of approximately -2.86% earlier. No specific news was identified to explain the decline.

2026-07-29 22:02; UTC

Biogen Inc shares are higher in after-market hours, maintaining a steady upward trajectory since Wednesday's close and staying above the 20-day moving average.

2026-07-28 22:01; UTC

Biogen Inc shares are higher in after-market hours, though no specific news was identified to explain the movement. The stock remains above its 20-day moving average.

2026-07-27 18:56; UTC

Biogen Inc. shares are lower today amid routine trading fluctuations. Broader market declines are influenced by falling oil prices ahead of the Federal Reserve meeting.

2026-07-24 18:26; UTC

Biogen Inc. shares are higher today, continuing an upward trend since Thursday. The stock's movement appears independent of recent oil price volatility.

2026-07-22 22:01; UTC

Biogen Inc shares are trading higher in after-market hours, reflecting an increase since Wednesday's close amid broader market volatility and rising crude oil prices.